vs
Side-by-side financial comparison of Clearwater Paper Corp (CLW) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3M vs $207.8M, roughly 1.7× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -3.6%, a 60.9% gap on every dollar of revenue.
Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
CLW vs IDYA — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.3M | $207.8M |
| Net Profit | $-12.8M | $119.2M |
| Gross Margin | -0.2% | — |
| Operating Margin | — | 52.2% |
| Net Margin | -3.6% | 57.4% |
| Revenue YoY | -4.7% | — |
| Net Profit YoY | -103.2% | 330.1% |
| EPS (diluted) | — | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $360.3M | — | ||
| Q4 25 | $386.4M | — | ||
| Q3 25 | $399.0M | $207.8M | ||
| Q2 25 | $391.8M | — | ||
| Q1 25 | $378.2M | — | ||
| Q4 24 | $387.1M | — | ||
| Q3 24 | $393.3M | $0 | ||
| Q2 24 | $344.4M | $0 |
| Q1 26 | $-12.8M | — | ||
| Q4 25 | $38.3M | — | ||
| Q3 25 | $-53.3M | $119.2M | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $-6.3M | — | ||
| Q4 24 | $199.1M | — | ||
| Q3 24 | $5.8M | $-51.8M | ||
| Q2 24 | $-25.8M | $-52.8M |
| Q1 26 | -0.2% | — | ||
| Q4 25 | 4.5% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | -0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | -13.9% | 52.2% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -4.0% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | -13.6% | — |
| Q1 26 | -3.6% | — | ||
| Q4 25 | 9.9% | — | ||
| Q3 25 | -13.4% | 57.4% | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | -7.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.36 | — | ||
| Q3 25 | $-3.30 | $1.33 | ||
| Q2 25 | $0.17 | — | ||
| Q1 25 | $-0.38 | — | ||
| Q4 24 | $11.87 | — | ||
| Q3 24 | $0.35 | $-0.60 | ||
| Q2 24 | $-1.55 | $-0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.5M | $786.9M |
| Total DebtLower is stronger | $361.1M | — |
| Stockholders' EquityBook value | $813.8M | $1.1B |
| Total Assets | $1.6B | $1.2B |
| Debt / EquityLower = less leverage | 0.44× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $36.5M | — | ||
| Q4 25 | $30.7M | — | ||
| Q3 25 | $34.4M | $786.9M | ||
| Q2 25 | $46.7M | — | ||
| Q1 25 | $44.0M | — | ||
| Q4 24 | $79.6M | — | ||
| Q3 24 | $35.5M | $920.0M | ||
| Q2 24 | $39.6M | $701.7M |
| Q1 26 | $361.1M | — | ||
| Q4 25 | $346.8M | — | ||
| Q3 25 | $337.0M | — | ||
| Q2 25 | $330.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $283.4M | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | $813.8M | — | ||
| Q4 25 | $825.3M | — | ||
| Q3 25 | $783.0M | $1.1B | ||
| Q2 25 | $836.8M | — | ||
| Q1 25 | $836.6M | — | ||
| Q4 24 | $854.6M | — | ||
| Q3 24 | $664.6M | $1.2B | ||
| Q2 24 | $658.6M | $931.7M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $2.5B | $1.2B | ||
| Q2 24 | $2.5B | $973.7M |
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.42× | — | ||
| Q3 25 | 0.43× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 1.73× | — | ||
| Q2 24 | 1.74× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.0M | — | ||
| Q3 25 | $34.0M | $142.2M | ||
| Q2 25 | $-28.2M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $-35.1M | — | ||
| Q3 24 | $16.2M | $-49.2M | ||
| Q2 24 | $21.1M | $-32.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-9.9M | — | ||
| Q3 25 | $15.7M | $142.2M | ||
| Q2 25 | $-51.1M | — | ||
| Q1 25 | $-31.2M | — | ||
| Q4 24 | $-68.1M | — | ||
| Q3 24 | $-30.8M | $-49.7M | ||
| Q2 24 | $3.0M | $-33.9M |
| Q1 26 | — | — | ||
| Q4 25 | -2.6% | — | ||
| Q3 25 | 3.9% | 68.4% | ||
| Q2 25 | -13.0% | — | ||
| Q1 25 | -8.2% | — | ||
| Q4 24 | -17.6% | — | ||
| Q3 24 | -7.8% | — | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.9% | — | ||
| Q3 25 | 4.6% | 0.0% | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | 12.0% | — | ||
| Q2 24 | 5.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | -10.44× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.18× | — | ||
| Q3 24 | 2.79× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
